These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15052222)

  • 1. Effect of gender on bridging to transplantation and posttransplantation survival in patients with left ventricular assist devices.
    Morgan JA; Weinberg AD; Hollingsworth KW; Flannery MR; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1193-5. PubMed ID: 15052222
    [No Abstract]   [Full Text] [Related]  

  • 2. Does bridging to transplantation with a left ventricular assist device adversely affect posttransplantation survival? A comparative analysis of mechanical versus inotropic support.
    Morgan JA; Park Y; Kherani AR; Vigilance DW; Cheema FH; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2003 Oct; 126(4):1188-90. PubMed ID: 14566269
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimal timing of cardiac transplantation after ventricular assist device implantation.
    Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk?
    Williams M; Casher J; Joshi N; Hankinson T; Warren M; Oz M; Naka Y; Mancini D
    J Thorac Cardiovasc Surg; 2003 Aug; 126(2):436-41. PubMed ID: 12928641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation management of left ventricular assist devices.
    Connors JM
    Am J Hematol; 2015 Feb; 90(2):175-8. PubMed ID: 25163820
    [No Abstract]   [Full Text] [Related]  

  • 8. Transplant registrants with implanted left ventricular assist devices have insufficient risk to justify elective organ procurement and transplantation network status 1A time.
    Dardas T; Mokadam NA; Pagani F; Aaronson K; Levy WC
    J Am Coll Cardiol; 2012 Jul; 60(1):36-43. PubMed ID: 22541833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged continuous-flow left ventricular assist device support and posttransplantation outcomes: A new challenge.
    Fukuhara S; Takeda K; Polanco AR; Takayama H; Naka Y
    J Thorac Cardiovasc Surg; 2016 Mar; 151(3):872-880.e5. PubMed ID: 26896362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices.
    Brilakis ES; Olson LJ; Berry GJ; Daly RC; Loisance D; Zucker M; Cooper LT
    ASAIO J; 2000; 46(5):569-72. PubMed ID: 11016508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Timing of Heart Transplant After HeartMate II Left Ventricular Assist Device Implantation.
    Steffen RJ; Blackstone EH; Smedira NG; Soltesz EG; Hoercher KJ; Thuita L; Starling RC; Mountis M; Moazami N
    Ann Thorac Surg; 2017 Nov; 104(5):1569-1576. PubMed ID: 28651783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
    Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplant and ventricular assist devices: gender differences in application and implementation.
    Shumway S
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1253-5. PubMed ID: 15115979
    [No Abstract]   [Full Text] [Related]  

  • 14. Left ventricular assist device as a bridge to partial left ventriculectomy.
    Frazier OH
    Eur J Cardiothorac Surg; 1999 Jan; 15 Suppl 1():S20-5; discussion S39-43. PubMed ID: 10077391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Ventricular Assist Devices: A Rapidly Evolving Alternative to Transplant.
    Mancini D; Colombo PC
    J Am Coll Cardiol; 2015 Jun; 65(23):2542-55. PubMed ID: 26065994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biventricular Berlin Heart EXCOR pediatric use across the united states.
    Zafar F; Jefferies JL; Tjossem CJ; Bryant R; Jaquiss RD; Wearden PD; Rosenthal DN; Cabrera AG; Rossano JW; Humpl T; Morales DL
    Ann Thorac Surg; 2015 Apr; 99(4):1328-34. PubMed ID: 25704863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in continuous-flow left ventricular assist device therapy as a bridge to transplantation: a risk-adjusted comparison using a propensity score-matching analysis.
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; García Sáez D; Amrani M; Bahrami T; De Robertis F; Wahlers T; Banner NR; Popov AF; Simon AR
    Artif Organs; 2015 Mar; 39(3):212-9. PubMed ID: 25175547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device related infections while on left ventricular assist device support do not adversely impact bridging to transplant or posttransplant survival.
    Morgan JA; Park Y; Oz MC; Naka Y
    ASAIO J; 2003; 49(6):748-50. PubMed ID: 14655747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation.
    Reinhartz O; Farrar DJ; Hershon JH; Avery GJ; Haeusslein EA; Hill JD
    J Thorac Cardiovasc Surg; 1998 Oct; 116(4):633-40. PubMed ID: 9766593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.